One-year clinical outcomes of bivalirudin versus unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention.

Yulong Li,Jiawen Li,Changdong Guan,Shuhong Su,Zhifang Wang,Haiwei Liu,Yuejin Yang,Runlin Gao,Jinqing Yuan,Xueyan Zhao

Diabetes & metabolic syndrome（2023）

引用 0|浏览10

暂无评分

摘要

Although diabetes is considered a high-risk factor for poor prognosis, compared with UFH (with or without GPI), bivalirudin did not increase the risk of MACCE and even decreased the risk of MI in patients with T2D undergoing elective PCI, while the risk of bleeding was similar between two groups.

查看译文

关键词

unfractionated heparin,percutaneous coronary intervention,bivalirudin,diabetes,clinical outcomes,one-year

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要